Martingale Asset Management L P Spero Therapeutics, Inc. Transaction History

Martingale Asset Management L P

  • $4.27 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 10, 2021
SELL
$11.65 - $22.07 $511,528 - $969,049
-43,908 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$8.96 - $14.12 $300,160 - $473,020
-33,500 Reduced 43.28%
43,908 $490,000
Q2 2020

Aug 10, 2020
BUY
$7.27 - $14.18 $562,756 - $1.1 Million
77,408 New
77,408 $1.05 Million

Others Institutions Holding SPRO

# of Institutions
49
Shares Held
13.9M
Call Options Held
200
Put Options Held
200
View Full List

About Spero Therapeutics, Inc.

SPRO Quotes by TradingView
  • Ticker SPRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,067,500
  • Market Cap $33.3M
  • Description
  • Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...
More about SPRO
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email